Robinhood - New Portfolio

Mark Sheppard

Robinhood
Individual Investor
Ranked #286,622 out of 766,394 TipRanks' Investors
Success Rate
52%
29 out of 56
profitable transactions
Average Return
15.71%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 7.71%
6-Month Return-
12-Month Return-
YTD Return▲ 2.36%
Total Return▲ 2.36%

Best Trade

Opened at
Closed at
Gain▲ 852.38%

Bio

Performance

25.72%0-25.72%
▼ 12.40%
▼ 4.03%
Apr 2024
▲ 11.46%
▲ 5.06%
May 2024
▼ 2.25%
▲ 3.53%
Jun 2024
▲ 25.72%
▲ 1.21%
▼ 4.84%
Jul 2024
▼ 4.22%
▲ 2.34%
▼ 6.95%
Aug 2024
▲ 7.82%
▲ 2.10%
▲ 0.08%
Sep 2024
▲ 6.02%
▼ 0.89%
▲ 4.11%
Oct 2024
▲ 22.71%
▲ 5.30%
▲ 10.95%
Nov 2024
TipRanks AverageS&P 500Investor Portfolio
▼ 12.40%▼ 4.03%
▲ 11.46%▲ 5.06%
▼ 2.25%▲ 3.53%
▲ 25.72%▲ 1.21%▼ 4.84%
▼ 4.22%▲ 2.34%▼ 6.95%
▲ 7.82%▲ 2.10%▲ 0.08%
▲ 6.02%▼ 0.89%▲ 4.11%
▲ 22.71%▲ 5.30%▲ 10.95%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
ChainLink
3.29%
▲ 12.56%
4
Buy
Nov 12, 2024
SoundHound AI, Inc Class A
5.26%
▲ 85.00%
3
Buy
Nov 12, 2024
Amazon
▼ 1.99%
4
Close
Nov 11, 2024
Direxion Daily Semiconductor Bull 3x Shares
▼ 26.32%
5
Close
Nov 11, 2024
Tenaya Therapeutics
0.71%
▼ 6.88%
1
Open
Nov 08, 2024
Jasper Therapeutics
▲ 12.35%
4
Close
Nov 07, 2024
Skye Bioscience
1%
▲ 11.54%
4
Buy
Nov 07, 2024
Tevogen Bio Holdings
▼ 46.23%
4
Close
Nov 07, 2024
AGNC Investment
▼ 9.48%
2
Close
Nov 04, 2024
COMPASS Pathways
▼ 36.33%
2
Close
Nov 01, 2024
Super Micro Computer
▼ 9.17%
6
Close
Nov 01, 2024
BioVie
▲ 2.32%
3
Close
Nov 01, 2024
Arcturus Therapeutics
▼ 19.39%
4
Close
Oct 30, 2024
Nukkleus
▲ 852.38%
2
Close
Oct 25, 2024
YieldMax TSLA Option Income Strategy ETF
3.15%
▲ 44.00%
1
Open
Oct 23, 2024
YieldMax NVDA Option Income Strategy ETF
4.17%
▲ 9.91%
4
Buy
Oct 22, 2024
Inozyme Pharma
▲ 9.81%
2
Close
Oct 17, 2024
TuHURA Biosciences
▼ 6.30%
2
Close
Oct 17, 2024
Viking Therapeutics
0.65%
▼ 0.62%
3
Open
Oct 12, 2024
Broadcom
18.86%
▲ 8.89%
3
Buy
Sep 27, 2024